Search research articles
Contact Us
Filters
Showing results (131-140 of 173) with videos related to
Page
of 18
Sort By:
Neurology
|
October 26, 1999
Elevated CSF prostaglandin E2 levels in patients with probable AD
T J Montine, K R Sidell, B C Crews, et al.
Clinical Nephrology
|
October 3, 2002
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients
T A Ikizler, J D Morrow, L J Roberts, et al.
International Journal of Sports Medicine
|
September 12, 2003
Immune and oxidative changes during and following the Western States Endurance Run
D C Nieman, C I Dumke, D A Henson, et al.
Journal of Neuropathology and Experimental Neurology
|
December 22, 1999
Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitis
T Valyi-Nagy, K R Sidell, L J Marnett, et al.
The Journal of Biological Chemistry
|
June 20, 1997
Antioxidant activity of vitamin C in iron-overloaded human plasma
T M Berger, M C Polidori, A Dabbagh, et al.
Chest
|
November 20, 2001
Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension
I M Robbins, R J Barst, L J Rubin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 7, 2001
Interactions between apolipoprotein E gene and dietary alpha-tocopherol influence cerebral oxidative damage in aged mice
E E Reich, K S Montine, M D Gross, et al.
Kidney International
|
October 24, 2000
F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes
A Montero, K A Munger, R Z Khan, et al.
The Journal of Biological Chemistry
|
June 5, 1998
Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid
L J Roberts, T J Montine, W R Markesbery, et al.
Journal of Lipid Mediators
|
March 1, 1993
Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome
J D Morrow, K P Moore, J A Awad, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 173) with videos related to
Sort By:
Page
of 18
Neurology
|
October 26, 1999
Elevated CSF prostaglandin E2 levels in patients with probable AD
T J Montine, K R Sidell, B C Crews, et al.
Clinical Nephrology
|
October 3, 2002
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients
T A Ikizler, J D Morrow, L J Roberts, et al.
International Journal of Sports Medicine
|
September 12, 2003
Immune and oxidative changes during and following the Western States Endurance Run
D C Nieman, C I Dumke, D A Henson, et al.
Journal of Neuropathology and Experimental Neurology
|
December 22, 1999
Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitis
T Valyi-Nagy, K R Sidell, L J Marnett, et al.
The Journal of Biological Chemistry
|
June 20, 1997
Antioxidant activity of vitamin C in iron-overloaded human plasma
T M Berger, M C Polidori, A Dabbagh, et al.
Chest
|
November 20, 2001
Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension
I M Robbins, R J Barst, L J Rubin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 7, 2001
Interactions between apolipoprotein E gene and dietary alpha-tocopherol influence cerebral oxidative damage in aged mice
E E Reich, K S Montine, M D Gross, et al.
Kidney International
|
October 24, 2000
F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes
A Montero, K A Munger, R Z Khan, et al.
The Journal of Biological Chemistry
|
June 5, 1998
Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid
L J Roberts, T J Montine, W R Markesbery, et al.
Journal of Lipid Mediators
|
March 1, 1993
Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome
J D Morrow, K P Moore, J A Awad, et al.
Page
of 18